|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C12N 5/0783 | (2010.01) |
| A61K 35/17 | (2015.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Patento numeris | 3129470 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15719043.0 |
| Europos patento paraiškos padavimo data | 2015-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data | 2021-07-12 |
| (86) | Numeris | PCT/US2015/024671 |
| Data | 2015-04-07 |
| (87) | Numeris | WO 2015/157252 |
| Data | 2015-10-15 |
| (30) | Numeris | Data | Šalis |
| 201461976396 P | 2014-04-07 | US | |
| 201462007309 P | 2014-06-03 | US | |
| 201462036493 P | 2014-08-12 | US | |
| 201462076238 P | 2014-11-06 | US | |
| 201462087888 P | 2014-12-05 | US | |
| 201462097278 P | 2014-12-29 | US |
| (72) |
BYRD, John, US
DUBOVSKY, Jason, US
FRAIETTA, Joseph, US
GILL, Saar, US
GLASS, David, US
JOHNSON, Amy, US
JUNE, Carl, H., US
KENDERIAN, Saad, US
MANNICK, Joan, US
MAUS, Marcela, US
MURPHY, Leon, US
MUTHUSAMY, Natarajan, US
PORTER, David, L., US
RUELLA, Marco, US
SELLERS, William, Raj, US
WASIK, Mariusz, US
BROGDON, Jennifer, US
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
The Trustees of The University of Pennsylvania, 3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US |
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Vėžio gydymas naudojant anti-CD19 chimerinį antigeno receptorių |
| TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2026-03-18 | 12 | 289.00 EUR |
| 2027-04-07 |